Cytra-k Crystals
NDC Package 60258-005-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Cytra-k Crystals is an effective alkalinizing agent useful in those conditions where long-term maintenance of an alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract, especially when the administration of sodium salts is undesirable or contraindicated. Marketed by Cypress Pharmaceutical, Inc., this product is identified by NDC 60258-005.

Identification & Billing

NDC Package Code
60258-005-01
Package Description
100 GRANULE, FOR SOLUTION in 1 BOX
Product Code
60258-005
11-Digit Billing Format
60258000501
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 1652634 - potassium citrate 3300 MG / citric acid 1002 MG Powder for Oral Solution
  • RxCUI: 1652634 - citric acid 1002 MG / potassium citrate 3300 MG Powder for Oral Solution
  • RxCUI: 1652634 - Citric Acid 1002 MG / K+ citrate 3300 MG Powder for Oral Solution
  • RxCUI: 1652634 - Citric Acid 1002 MG / Pot citrate 3300 MG Powder for Oral Solution
  • RxCUI: 1652638 - CYTRA-K CRYSTALS 3300 MG / 1002 MG Powder for Oral Solution

Clinical Specifications

Proprietary Name
Cytra-k Crystals
Dosage Form
-
Usage Information
CYTRA-K CRYSTALS is an effective alkalinizing agent useful in those conditions where long-term maintenance of an alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract, especially when the administration of sodium salts is undesirable or contraindicated. In addition, it is a valuable adjuvant when administered with uricosuric agents in gout therapy, since urates tend to crystallize out of an acid urine. It is also effective in correcting the acidosis of certain renal tubular disorders where the administration of potassium citrate may be preferable. CYTRA-K CRYSTALS is highly concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. CYTRA-K CRYSTALS alkalinizes the urine without producing a systemic alkalosis in recommended dosage. It is highly palatable, pleasant tasting, and tolerable, even when administered for long periods. Potassium citrate does not neutralize the gastric juice or disturb digestion.

Regulatory & Marketing

Labeler Name
Cypress Pharmaceutical, Inc.
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
05-01-2003
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60258-005-01 identifies a specific commercial package of 100 granule, for solution in 1 box of Cytra-k Crystals, labeled by Cypress Pharmaceutical, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cypress Pharmaceutical, Inc. on May 01, 2003. The current certification is valid through December 31, 2018.

How is this Cypress Pharmaceutical, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60258000501. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
60258-005-01
11-Digit CMS (5-4-2)
60258-0005-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.